# Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer

> **NCT00003893** · PHASE3 · COMPLETED · sponsor: **University Hospital Birmingham** · enrollment: 2250 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** CMF regimen
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** epirubicin hydrochloride
- **DRUG:** fluorouracil
- **DRUG:** methotrexate
- **DRUG:** mitomycin C
- **DRUG:** mitoxantrone hydrochloride
- **PROCEDURE:** adjuvant therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003893
- **Lead sponsor:** University Hospital Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-07
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 2250 (ESTIMATED)
- **Last updated:** 2013-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003893, "Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00003893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*